Centre for Primary Care Seminar Series seminar
| Dates: | 5 November 2013 |
|---|
| Times: | 14:00 - 15:00 |
|---|
| What is it: | Seminar |
|---|
| Organiser: | Institute of Population Health |
|---|
| Who is it for: | University staff |
|---|
|
Host: Institute of Population Health
Title:
Can more frequent HbA1c measurements be used to titrate diabetes medication?
Diabetes is a major and increasing health problem and maintaining good glycaemic control is crucial to good diabetes care. The recommended monitoring interval for HbA1c in type 2 diabetes is 3 to 6 months, but this is based on expert opinion. We carried out a 12-week cohort study to explore whether routine HbA1c testing intervals before 12 weeks has potential to inform diabetes medication adjustments following a medication change. HbA1c was measured at frequent time intervals in 79 patients with type 2 diabetes who had had a change in their oral diabetes medication. Results from this study will be presented and the value of measuring HbA1c at shorter time intervals in certain patients will be discussed.
Speaker:
Jenny Hirst, NIHR Doctoral Research Fellow, Department of Primary Care Health Sciences, University of Oxford
Travel and Contact Information
Find event
Seminar room 1, 5th floor
Williamson Building
Manchester
